is metformin a glp 1 receptor agonist and Glucagon-like peptide-1 (GLP-1) inhibit Adenosine Diabetic Agents, From Metformin to
Description
Some clinicians have adopted this reasoning and prescribe both medications off-label, particularly phentermine combined with semaglutide or phentermine combined with tirzepatide
Low blood sugar (hypoglycemia)
British Journal of Pharmacology, 39 (1), 16.
[DOI] [PubMed] [Google Scholar] 147
Other GLP-1 receptor agonists that are FDA-approved to treat type 2 diabetes and may lead to weight loss include: Dulaglutide (Trulicity) Exenatide (Bydureon) Lixisenatide (Adlyxin) Other forms of semaglutide (Ozempic and Rybelsus) Many diabetes medications and insulin reduce blood sugars but also contribute to weight gain
